Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / GILD - ViiV says its HIV PrEP therapy outperformed Gilead's lenacapavir in early-stage trial

GILD - ViiV says its HIV PrEP therapy outperformed Gilead's lenacapavir in early-stage trial

Gilead Sciences Inc.

2025-10-15 07:49:59 ET

More on Pfizer, GSK, etc.

For further details see:

ViiV says its HIV PrEP therapy outperformed Gilead’s lenacapavir in early-stage trial

Stock Information
Company Name: Gilead Sciences Inc.
Stock Symbol: GILD
Market: NASDAQ
Website: gilead.com
Menu
GILD GILD Quote GILD Short GILD News GILD Articles GILD Message Board
Get GILD Alerts

News, Short Squeeze, Breakout and More Instantly...